Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001301501-15-000008
Filing Date
2015-04-13
Accepted
2015-04-13 16:14:06
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A akao-12312014x10xka.htm 10-K/A 285305
2 EXHIBIT 10.2(B) a10-kaexhibit102b.htm EX-10.2(B) 6797
3 EXHIBIT 10.3(M) a10-kaexhibit103m.htm EX-10.3(M) 41945
4 EXHIBIT 10.3(N) a10-kaexhibit103n.htm EX-10.3(N) 39181
5 EXHIBIT 10.3(O) a10-kaexhibit103o.htm EX-10.3(O) 37232
6 EXHIBIT 10.3(P) a10-kaexhibit103p.htm EX-10.3(P) 38304
7 EXHIBIT 10.3(Q) a10-kaexhibit103q.htm EX-10.3(Q) 38990
8 EXHIBIT 31.3 a10-kaexhibit313.htm EX-31.3 5608
9 EXHIBIT 31.4 a10-kaexhibit314.htm EX-31.4 5648
  Complete submission text file 0001301501-15-000008.txt   500045
Mailing Address 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO CA 94080 650-800-3636
Achaogen Inc (Filer) CIK: 0001301501 (see all company filings)

EIN.: 680533693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36323 | Film No.: 15766908
SIC: 2834 Pharmaceutical Preparations